Company news

Cambium Bio Ltd news in 2019

Cambium Bio Ltd's news releases, calls and decks from 2019, newest first.

View company

AGC Agreement termination paves way for commercial partner

December 19, 2019

CEO Presentation to 2019 Annual General Meeting

November 21, 2019

Chairmans Address to Shareholders

November 21, 2019

Japanese Biotech Fund takes up all Rights Issue Shortfall

November 19, 2019

Regeneus receives A$1.5 million in R&D Tax Incentives

October 15, 2019

Appendix 4E

August 29, 2019

Restructuring results in 50% reduction in operating costs

August 13, 2019

Updated Investor Presentation

August 7, 2019

Offer Booklet

August 1, 2019

Investor Presentation

August 1, 2019

Successful Private Placement

August 1, 2019

Positive results for Progenza in treating neuropathic pain

July 23, 2019

Directors Provide $2.5M Loan to Extend Funding Runway

February 28, 2019

Response to ASX Appendix 4C Query Letter

February 21, 2019

New CEO Appointed to Accelerate Global Growth

January 22, 2019

Decks in 2019